Olfr506, a member of the olfactory receptor family, plays a pivotal role in initiating the neuronal response responsible for the perception of various smells. As a G-protein-coupled receptor (GPCR), Olfr506 shares a structural framework characterized by a 7-transmembrane domain, akin to other neurotransmitter and hormone receptors. Encoded by single coding-exon genes, olfactory receptors exhibit a unique nomenclature independent of other organisms, constituting the largest gene family within the genome. The function of Olfr506 involves the recognition and G protein-mediated transduction of odorant signals, a process vital for the olfactory system's proper functioning. In the intricate landscape of olfactory signal transduction, Olfr506 emerges as a key player. Upon interaction with odorant molecules, a cascade of events is triggered, leading to the initiation of a neuronal response and the subsequent perception of a distinct smell. This response is mediated by the activation of G proteins, setting off a series of signaling events that culminate in the perception of the olfactory stimulus. The receptor's involvement in this intricate process positions it as a critical component in the sensory system, contributing significantly to the richness and diversity of our olfactory experiences.
Efforts to modulate Olfr506 function and, by extension, olfactory signaling, involve the identification and exploration of inhibitors that act either directly or indirectly on this receptor. Direct inhibitors may interact with Olfr506 itself, hindering its ability to recognize and transduce odorant signals. Indirect inhibitors, on the other hand, influence the cellular and biochemical pathways associated with olfactory signal transduction, affecting the receptor's function in a more circuitous manner. These pathways include but are not limited to the Folate, Hedgehog, PI3K/Akt, MAPK, and p38 MAPK pathways. The modulation of these pathways, achieved through the application of specific inhibitors, offers a nuanced approach to influencing Olfr506 activity, providing potential avenues for the regulation of olfactory perception. In summary, Olfr506 serves as a linchpin in olfactory signal transduction, and the pursuit of inhibitors represents a strategic means to unravel the intricacies of its function and its impact on our olfactory experiences.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Folate pathway inhibitor disrupting the synthesis of purines and pyrimidines. By inhibiting dihydrofolate reductase, it hinders the production of crucial precursors, indirectly affecting Olfr506 function within the signaling cascade. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
DNA cross-linking agent causing DNA damage and activating p53-mediated apoptosis. The consequential cellular stress response influences downstream pathways, indirectly impacting Olfr506 signaling through interconnected cellular processes. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Hedgehog pathway inhibitor targeting Smoothened. Disruption of this pathway influences downstream cellular events, potentially modulating Olfr506 expression and signaling cascades indirectly through cross-talk mechanisms. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3-kinase inhibitor impeding the PI3K/Akt pathway. Interference with this pathway may indirectly affect Olfr506 by altering downstream signaling events, illustrating a potential indirect inhibitory role in olfactory receptor signaling. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Thymidylate synthase inhibitor disrupting DNA synthesis. The resulting perturbation in nucleotide production influences cellular processes, potentially affecting Olfr506 indirectly through altered signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor targeting the MAPK pathway. Inhibition of this pathway may indirectly modulate Olfr506 by affecting downstream events, showcasing a potential regulatory role in olfactory receptor signaling cascades. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid receptor agonist influencing gene expression. By modulating transcriptional events, ATRA could indirectly impact Olfr506 expression and signaling, providing a potential avenue for olfactory receptor inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor disrupting the p38 signaling pathway. Alterations in this pathway may indirectly influence Olfr506 function through interconnected cellular responses, suggesting a potential indirect regulatory role in olfactory signaling. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Glycolysis inhibitor affecting energy metabolism. Disruption of cellular energy balance may indirectly influence Olfr506 signaling, suggesting a potential regulatory role in olfactory receptor function through altered cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor disrupting the mTOR signaling pathway. Indirect modulation of cellular events downstream of mTOR may influence Olfr506 function, illustrating a potential regulatory role in olfactory receptor signaling cascades. | ||||||